mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.8 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.8 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.0073 |
0.8 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.8 |
mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
-0.0077 |
0.8 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.8 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.8 |
mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.9 |
mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.9 |